Markets Confusing? Ask Edgen Search.
Instant answers, zero BS, and trading decisions your future self will thank you for.
By Anna Kowalski | Senior Equity Analyst — Macro & Financials Published: May 11, 2026 Rating: Buy ($95 PT) Sector: Finance > Fintech & Payments Tickers: $AFRM | Related: $COIN, $V, $MA
Affirm crushed Q3 — adjusted EPS $0.37 against a $0.27 consensus, revenue $1.12B against $1.06B expected, FY26 guide raised to $4.18B-$4.21B. The stock closed Friday at $64.01, down 5%, after sitting flat through the after-hours session. Same thing happened on Q2: beat, then dipped 4.41%. Two consecutive beat-and-fade reactions tell you what the market is actually waiting for, and that thing arrives Tuesday, May 12, 2 PM to 5 PM Eastern, in person in New York and live on Affirm's IR webcast.
The forum delivers something Affirm has not given investors since the 2021 IPO: a medium-term financial framework. Five years of "here is the next quarter and a vague long-term ambition" — finally getting structure. Four specific numbers will land on those slides, and those four numbers decide which of three scenarios is playing out at Wednesday's open. They also tell you whether the sell-side's $75-90 zone (Morgan Stanley $79, Needham $90, Oppenheimer $87) is the right anchor, or whether our $95 Buy holds.
What is actually on the table tomorrow
Affirm's management has said publicly that the forum will cover four agenda blocks: company vision, commercial initiatives, product roadmap, and the medium-term financial framework itself. Sell-side preview notes from the last two weeks confirm two specific deep-dives baked into the agenda — UK expansion (Affirm's first material international market, launched in 2024 with Klarna-style positioning) and new verticals (rent payments, B2B installment products). Both are pre-revenue narratives today; both need quantification tomorrow to matter.
The framework block is what re-rates the stock. Everything else is context.
Number 1 — The FY28 revenue and GMV trajectory
Affirm's current FY26 guide is $4.18B-$4.21B revenue and roughly $35-37B GMV. The forum needs a credible glide path two years out. Sell-side models cluster at:
- Bull anchor: $6.0B+ revenue and $55B+ GMV in FY28 — implies ~22% revenue CAGR sustained through FY27-FY28, supported by UK scaling to material contribution and at least one new vertical hitting $100M+ run rate.
- Base anchor: $5.0-5.5B revenue, $45-50B GMV — implies ~15% CAGR, US business doing its job, UK and verticals as optionality not core.
- Bear anchor: management refuses to commit to a FY28 number, or names a range with a low end below $5.0B — read as the framework being defensive rather than ambitious.
The number you hear at 2:15 PM is the first signal. If FY28 revenue gets a hard number with a midpoint at or above $5.8B, the bull case is live.
Number 2 — The long-term operating margin target
Q3 adjusted operating margin was approximately 24%. GAAP operating margin remains negative, primarily because of stock-based compensation (still running at high mid-teens as a share of revenue) and mark-to-market volatility on held loans. Both are real expenses, both matter for valuation, and the framework needs to anchor a multi-year path on at least one of these dimensions.
- Bull: GAAP operating margin 15-20% by FY28, with explicit stock-comp dollar caps that imply percentage decline.
- Base: GAAP operating margin 5-10% by FY28, with stock-comp described as "trending lower" without dollar anchors.
- Bear: framework provides adjusted operating margin only, leaves GAAP unaddressed. Translation: management is not yet willing to commit to a GAAP profitability date.
The market has been pricing AFRM on adjusted EBITDA for three years. A real GAAP anchor changes the valuation conversation.
Number 3 — Warehouse capacity and funding mix
Affirm currently funds roughly $15B of consumer loan capacity, mixed approximately 60% bank warehouse lines, 30% securitization, 10% loan sales / forward-flow agreements. The Q3 print disclosed that loan sale momentum is accelerating — institutional buyers want the paper.
The framework needs to commit to direction:
- Bull: an explicit shift toward 40-50% loan sales by FY28. This is a capital-light pivot — Affirm earns origination + servicing fees and holds less credit risk on the balance sheet. The valuation multiple expands because earnings volatility drops.
- Base: status quo mix, with funding capacity ramped to $20-22B to support FY28 volume.
- Bear: no explicit funding mix target, or a target that keeps warehouse share above 55% — implies the credit cycle risk stays on Affirm's balance sheet at scale.
This is the number most retail readers will miss and the one that determines whether AFRM trades like a payments network or a specialty consumer lender.
Number 4 — 0% APR vs interest-bearing mix
Affirm's loan book splits roughly 35% 0% APR (merchant-subsidized) and 65% interest-bearing (consumer pays). The economics are very different. 0% APR loans look like interchange — Affirm collects a merchant fee, takes minimal credit risk, the borrower is a high-quality buyer of a high-ticket item (Peloton, Apple, etc.). Interest-bearing loans look like a fintech lender — yield is higher, credit risk is real, the book is exposed to the consumer credit cycle.
- Bull: management commits to 50%+ 0% APR mix by FY28, framing the business as a payments network with credit attached, not the other way around.
- Base: mix stable around current 35/65, framework treats both segments as core.
- Bear: management signals the higher-yield interest-bearing book is the growth engine, increasing exposure to the cycle.
The 0% APR pivot is the case for AFRM trading at payments-network multiples (V/MA territory) instead of consumer-finance multiples (SoFi territory). Tomorrow tells you which the company is targeting.
Three reaction scenarios
| Scenario | What it looks like on the slides | Stock 24-hour reaction | Where it goes by month-end |
|---|---|---|---|
| Bull (35%) | $6B+ FY28 revenue, 15%+ GAAP margin path, 45%+ loan sale share, 50% 0% APR mix, UK quantified | +15% to +25% | $78-85 |
| Base (45%) | $5.0-5.5B FY28 revenue, 5-10% GAAP margin, status quo funding mix, UK described qualitatively | -3% to +5% | $62-68 |
| Bear (20%) | No FY28 number, no GAAP anchor, mix targets vague, UK and B2B treated as optionality | -10% to -15% | $54-58 |
Probability-weighted 24-hour outcome: roughly $68 — about 6% above Friday's close. That is the binary-event premium being paid right now. The 18-month thesis is different: our $95 Buy assumes the Bull case partially materializes (specifically the loan sale shift plus UK scaling to a $200M+ FY27 contribution) and that the consumer credit cycle stays benign through 2027. The 24-hour outcome and the 18-month thesis are not the same question.
Counterargument — what if the framework is a nothingburger
Some companies use these events as glorified earnings updates with longer slide decks. If Affirm's forum delivers no FY28 number, no GAAP commitment, and treats UK plus B2B as "exciting opportunities we'll update you on later," the stock fades back to the low $60s and the medium-term thesis becomes a pure credit-cycle bet. That bet is fine — Affirm is well-positioned for a benign cycle — but it is not what the $95 anchor reflects.
The 2 PM to 5 PM window tomorrow tells you whether the binary re-rating is happening or whether the question gets punted another quarter. Q3 already showed that beating numbers no longer moves AFRM. Only the framework can.
How this fits with our prior AFRM coverage
This is the third article in our AFRM forum series. The first, our May 1 pre-event thesis, made the case for positioning before Q3 because the forum was the real catalyst. The second, our May 8 post-Q3 diagnostic, explained why beat-and-fade was the predictable reaction. This third piece is the day-before decision framework. The pattern echoes our Coinbase OCC trust bank thesis from May 5 — fintech names where the structural catalyst is bigger than any single earnings print.
What to do if you already own AFRM
If you sized in pre-Q3 at $50-55, you are sitting on a 20-25% gain into a binary event. The asymmetric playbook: trim 25-30% into Tuesday's open at $64-66, hold the rest through the forum, re-evaluate Wednesday. The probability-weighted 24-hour outcome (+6%) does not justify pressing the position; the Bull-case 18-month outcome (+50% from current) justifies holding the core.
If you do not own it yet and the thesis appeals, the entry is harder. Buying at $64 the day before is paying the binary-event premium. Either wait for Wednesday's reaction to set a cleaner entry (Bear case = $56 entry, Base case = $63 entry, Bull case = entry was last week), or size small now and add on a Bear-case dip.
Conclusion
Four numbers. Three scenarios. Wednesday morning AFRM either re-rates toward $80 or fades toward $56. Our Buy $95 is the 18-month view, anchored on partial Bull case plus benign credit cycle. The 24-hour view is asymmetric Bull ($82, +28%) versus Bear ($56, -13%) at roughly 35/20 probability — that is the case for tactical positioning, not for sizing in fresh. The one thing to watch is the FY28 revenue number Affirm puts on a slide tomorrow at 2:15 PM ET. Everything else is commentary on that number.
FAQ
What time is the Affirm investor forum on May 12, 2026?
The forum runs from 2 PM to 5 PM Eastern Time on Tuesday, May 12, 2026, held in person in New York with a live webcast on Affirm's investor relations website. Management's prepared remarks will likely cover the medium-term financial framework in the opening 30-45 minutes, with Q&A in the back half.
Why is this forum more important than Q3 earnings?
Q3 already happened — adjusted EPS $0.37 against $0.27 expected, revenue $1.12B against $1.06B expected, FY26 guide raised. The stock dropped 5% anyway. That is the second consecutive beat-and-fade quarter for AFRM. The forum delivers Affirm's first medium-term financial framework since the 2021 IPO — multi-year revenue, margin, and capital-allocation targets the market has never had. That framework re-rates the stock; another quarterly beat does not.
What is Affirm's medium-term financial framework?
A medium-term financial framework is the multi-year financial guidance most public companies provide at investor days — typically a 2-3 year revenue trajectory, an operating margin glide path, and a capital allocation philosophy. Affirm has not provided one since its 2021 IPO, instead giving quarterly guidance only. The forum will deliver this for the first time, including specific targets across the four numbers above plus UK expansion contribution and new vertical scaling.
What should I do if I already own AFRM into the forum?
The asymmetric playbook is to trim 25-30% into Tuesday's open at $64-66 and hold the rest through the event. Probability-weighted 24-hour outcome is roughly $68 — a 6% binary-event premium that does not justify pressing the position size. The 18-month Bull case ($95+) justifies holding the core. This is the standard pre-binary-event approach for any name with asymmetric scenario distributions.
How do the 4 forum numbers compare to recent analyst price targets?
Sell-side has clustered at $75-90 following Q3: Morgan Stanley $79, Needham $90, Stephens $75, Baird $70, Oppenheimer $87. The midpoint of $80 is consistent with the Base-case scenario above ($5.0-5.5B FY28 revenue, status quo mix). Our $95 Buy sits 6% above the high end and requires the Bull case to partially materialize at the forum — specifically the loan-sale-mix shift plus UK quantification. If management delivers on Numbers 3 and 4 tomorrow, sell-side targets will revise toward our anchor.
This article is for informational purposes only and does not constitute investment advice. The author and Edgen do not hold positions in $AFRM at time of publication. Past performance is not indicative of future results. Forecast scenarios reflect probabilistic analysis and are not guarantees of outcome.
Your money person, finally.
Try Ed free. No credit card. No commitment.




